Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where James R. Bischoff is active.

Publication


Featured researches published by James R. Bischoff.


Science | 1996

An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells

James R. Bischoff; David Kirn; Angelica Williams; Carla Heise; Sharon Horn; Mike Muna; Lelia Ng; Julie Nye; Adam Sampson-Johannes; Ali Fattaey; Frank McCormick

The human adenovirus E1B gene encodes a 55-kilodalton protein that inactivates the cellular tumor suppressor protein p53. Here it is shown that a mutant adenovirus that does not express this viral protein can replicate in and lyse p53-deficient human tumor cells but not cells with functional p53. Ectopic expression of the 55-kilodalton EIB protein in the latter cells rendered them sensitive to infection with the mutant virus. Injection of the mutant virus into p53-deficient human cervical carcinomas grown in nude mice caused a significant reduction in tumor size and caused complete regression of 60 percent of the tumors. These data raise the possibility that mutant adenoviruses can be used to treat certain human tumors.


Science | 1996

The Candidates Speak: At the invitation of Science, President Bill Clinton and Senator Bob Dole have responded to a series of questions regarding science policy

James R. Bischoff; David Kirn; Angelica Williams; Carla Heise; Sharon Horn; Mike Muna; Lelia Ng; Julie Nye; Adam Sampson-Johannes; Ali Fattaey; Frank McCormick

An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells The human adenovirus E1B gene encodes a 55-kilodalton protein that inactivates the cellular tumor suppressor protein p53. Here it is shown that a mutant adenovirus that does not express this viral protein can replicate in and lyse p53-deficient human tumor cells but not cells with functional p53. Ectopic expression of the 55-kilodalton EIB protein in the latter cells rendered them sensitive to infection with the mutant virus. Injection of the mutant virus into p53-deficient human cervical carcinomas grown in nude mice caused a significant reduction in tumor size and caused complete regression of 60 percent of the tumors. These data raise the possibility that mutant adenoviruses can be used to treat certain human tumors.


Nature | 1993

Bcl-2 associates with the ras-related protein R-ras p23

Maria Jose Fernandez-Sarabia; James R. Bischoff


Biochemical Journal | 1994

The Ras-related protein R-ras interacts directly with Raf-1 in a GTP-dependent manner

M Spaargaren; G A Martin; Frank McCormick; M J Fernandez-Sarabia; James R. Bischoff


Archive | 1993

Bcl-2 and R-ras complex

James R. Bischoff; Maria Jose Fernandez-Sarabia


Archive | 1997

Cytopathic adenoviral E1B mutated viruses for therapy and prophylaxis of neoplasia

James R. Bischoff; Julie Nye; Lelia Ng; Sharon Horn; Angelica Williams; David Kirn


Archive | 1995

Interaction of BCL-2 and R-RAS

James R. Bischoff; Maria Jose Fernandez-Sarabia


Archive | 1995

p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME

James R. Bischoff; Lelia Wu


Archive | 1997

Cytopathic viruses for therapy and prophylaxis of neoplasia

James R. Bischoff; Julie Nye; Ng Lelia; Sharon Horn; Angelica Williams; David Kirn


Archive | 1997

Virus citopaticos para la terapia y profilaxis de neoplasia.

James R. Bischoff; Sharon Horn; David Kirn; Ng Lelia; Julie Nye; Angelica Williams

Collaboration


Dive into the James R. Bischoff's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lelia Ng

Onyx Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ng Lelia

Onyx Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge